Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future

PM Danzon, S Soumerai - The 13th Annual Herbert Lourie …, 2002 - papers.ssrn.com
Prescription drug expenditures make up less than 10 percent of total personal health care
expenditures in the United States, but over the last decade the amount that Americans …

[PDF][PDF] Why are prescription drug costs rising

DH Kreling, DA Mott, JB Wiederholt - Hospital, 1997 - evidence2impact.psu.edu
By David H. Kreling, David A. Mott, & Joseph. B. Wiederholt his chapter explains why
spending on prescription drugs has been one of the fastest-growing health care costs in the …

Setting Prescription Drug Prices: A Comparison of Strategies in the US, UK, Canada, Australia, and Germany.

J Luo, AS Kesselheim - Harvard Health Policy Review, 2016 - search.ebscohost.com
In 2015, Americans experienced dramatic increases in the prices of prescription drugs,
affecting many areas of medicine including infectious disease (hepatitis C), oncology …

[图书][B] Who Pays Higher Prices for Prescription Drugs?

AJ Rettenmaier, Z Wang - 2003 - ncpathinktank.org
For decades, medical expenditures have grown faster than the gross domestic product.
Moreover, spending for prescription drugs is the fastestrising component of health care …

[PDF][PDF] Health Insurance Expansions and Pharmaceutical Markets.

ME Blume-Kohout, N Sood - Harvard Health Policy Review, 2013 - drive.google.com
The Affordable Care Act (ACA) is expect-ed to dramatically increase health insurance
coverage in America, providing coverage for some 27 million uninsured Americans. This …

Handbook of Pharmaceutical Public Policy: Thomas R. Fulda & Albert I. Wertheimer, Eds.(Pharmaceutical Products Press, Binghamton, NY, 2007), 681 pages, $89.95

RI Field - 2008 - Taylor & Francis
When the Medicare program was created in 1965, outpatient prescription drugs were left out
of the benefit package, a decision that maintained consistency with standard private …

The price of progress: prescription drugs in the health care market

JD Kleinke - Health Affairs, 2001 - healthaffairs.org
Pharmacy costs are rising in excess of general and medical cost inflation, leading to calls for
price and utilization controls by public and private payers. Such controls would be ineffective …

The financial burden from prescription drugs has declined recently for the nonelderly, although it is still high for many

WF Gellad, JM Donohue, X Zhao, Y Zhang… - Health …, 2012 - healthaffairs.org
Prescription drug spending and pharmacy benefit design have changed greatly over the
past decade. However, little is known about the financial impact these changes have had on …

[PDF][PDF] Benefits, risks, and costs of prescription drugs: a scientific basis for evaluating policy options

GM Anderson, WO Spitzer, MC Weinstein… - Clinical Pharmacology …, 1990 - academia.edu
Governments and private insurers in North America are becoming increasingly involved in
providing coverage for prescription drugs. Although the catastrophic coverage provision …

[HTML][HTML] The promise of specialty pharmaceuticals

AR Weil - Health Affairs, 2014 - healthaffairs.org
The role of prescription drugs in meeting health care needs has raised thorny policy issues
for decades. Prescription drug spending grew 10 percent or more in real terms every year …